Published • loading... • Updated
Avidity Biosciences Announces Expected Record Date for Spin-Off
Summary by Helena Independent Record
21 Articles
21 Articles
+20 Reposted by 20 other sources
Avidity Biosciences Announces Expected Record Date for Spin-Off
SAN DIEGO, Feb. 2, 2026 /PRNewswire/ -- Avidity Biosciences, Inc. ("Avidity") (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates ("AOCs™") to profoundly improve people's lives, today announced that its board…
Coverage Details
Total News Sources21
Leaning Left0Leaning Right0Center11Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium












